BCD Bioscience

United Statesb-cd.app
series-a
series-a
Stage
1
Investors

About

BCD Bioscience develops proprietary technology to create precision oligosaccharides from natural fibers that act as prebiotics and immunomodulators for pharmaceutical and food ingredient applications.

Explore BCD Bioscience's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.